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Experimental tuberculosis has been widely used to study cell-mediated immunity to 
infection (1-3) and the regulation of delayed type hypersensitivity (DTH) 1 to tuberculin 
and other antigens (4, 5). After infection with Bacille-Calmette-Gu~rin (BCG), the host 
may acquire  immunity to  specific  secondary challenge,  protection against  unrelated 
virulent organisms such as Listeria monocytogenes  (6, 7), and also increased resistance 
to  transplantable  tumors  (8). The  macrophages become  activated,  display  increased 
spreading and metabolic activity in culture, and may develop an enhanced capacity to 
kill specific  as well as unrelated microorganisms.  One pathway for activating macro- 
phages depends on the generation of specifically sensitized thumus-derived (T) lympho- 
cytes (9,  10), but little is known about the mechanism of activation or the nature and 
control of interactions among T cells,  antigen, and macrophages. 
We have reported previously that  macrophages activated by various inflammatory 
and  endocytic stimuli  produce  and  secrete  high  levels  of neutral  protease  activities 
including plasminogen activator (PA; 11, 12), collagenase (13), and elastase (14). Because 
the PA provides a  sensitive measure of nonspecific macrophage activation and because 
antimicrobial  activity of macrophages against  slow growing and  resistant  organisms 
such as the tubercle bacillus is difficult to study (15), we asked whether macrophage PA 
could also be induced specifically, by infection with BCG. 
In this report we describe the effects of systemic BCG infection in the mouse 
on PA activity of the peritoneal macrophages and examine the role of sensitized 
lymphocytes and of challenge with purified protein derivative (PPD) in regulat- 
ing enzyme activity. Related studies on Trypanosoma  cruzi  infection in the 
mouse have been reported (16, 17). 
Materials and Methods 
Animals.  NCS female mice, weighing 25-30 g, from The Rockefeller University were used in 
all studies except where noted. Inbred strains BALB/cJ and C~H/HeJ mice were obtained from 
The Jackson Laboratory, Bar Harbor, Maine. 
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BCG Infection.  Mice were infected intravenously (10.1  ml) with 2-6 ×  10  ~ viable BCG (strain 
1011,  Trudeau  Institute,  Saranac Lake,  N.  Y.;  18).  Animals were kept six mice per cage,  and 
controls were kept under the same conditions for the same period of time.  BCG was stored at 
-70°C and thawed once before use. 
Peritoneal cells were harvested from infected or control mice at different times after infection, 
with  or  without  an  intraperitoneal challenge  with  one  of the following  agents  2  days  before 
harvest:  (a) Mycobacterium  tuberculosis,  strain Hs~Ra  (lyophilized; Difco Laboratories, Detroit, 
Mich.). Stock suspensions were sonicated 2 mg/ml in phosphate-buffered saline (PBS) with 0.1% 
bovine serum albumin and 500  gg in 1 ml PBS injected per mouse.  (b) M.  tuberculosis,  strain 
H3~Rv,  culture  filtrate  (CF;  19).  This  was  a  gift  from  Professor  M.  Chase,  The  Rockefeller 
University, and was injected  (0.01-10  ~g) in a solution  of  PBS containing 5 ~g/ml Tween 80 (ICI 
United States,  Inc.,  Wilmington, Del.).  (c)  Tuberculin PPD (lot  no. 16, Connaught Laboratories, 
Toronto, Canada), 50 /~g in 1 ml PBS. (d) Proteose peptone (Difco  Laboratories), 1 ml of a 1% 
solution. 
Cells.  For the purpose of  this  report cells  obtained from uninfected control  animals without 
intraperitoneal  challenge are termed "resident  cells."  Peritoneal cells  were harvested by conven- 
tional procedures  and were usually pooled from three to four mice. Cells  were washed and 
suspended in culture medium consisting of Dulbecco's medium  (H-21; Grand Island Biological 
Co., Grand Island,  N. Y.) supplemented with 2% fetal  bovine serum (FBS), 100 U/ml penicillin, 
100 ~g/ml streptomycin, and 5 × 10  -5  M  mercaptoethanol (D2FBS). Cell  yields  from BCG-infected 
animals were 5-9 × 106 and contained 40-60% macrophages, with the remainder lymphocytes. 
Uninfected animals gave similar cell  yields with 25-40% macrophages. Cell suspensions were 
distributed  in multiwell Linbro plates  (Linbro Chemical Co.,  New Haven, Conn.) with or  without 
l~sI-fibrin. Unless noted otherwise each well contained 1 ×  l0  s peritoneal cells of which 3-5 x  l0  s 
were macrophages. 
Peritoneal cell cultures were either left unwashed and incubated further, with or without PPD, 
or were incubated for 2-4 h at 37°C and washed twice with Hanks' Balanced Salt Solution (HBSS) 
to remove most of the lymphocytes. These macrophage monolayers were refed D2FBS and used as 
described below. 
Higher cell yields were obtained from infected animals challenged in vivo with the various 
agents listed above, 8-15  ×  106 cells per mouse,  with 5-20% polymorphonuclear luekocytes,  30- 
60% macrophages, and 30-50% lymphocytes. For these experiments, serial dilutions of cells were 
cultivated on 12sI-fibrin in Dulbecco's medium, antibiotics, and 20% FBS (D20FBS), with 60 ~g/ml 
soybean trypsin inhibitor (STI fraction V,  Miles Laboratories Inc., Elkhart,  Ind.), to suppress 
fibrinolysis. The adherent cells were washed well, refed after 2-4 h, and incubated further in the 
same medium for at least 24 h  to ensure loss of polymorphonuclear leukocytes (12). 
Nylon-Wool  Separation of Lymphocytes.  Suspensions of peritoneal cells, 2-4 ×  l0  T cells in 1-2 
ml, were obtained in Dulbecco's medium +  10% heat-inactivated FBS +  5 ×  10 -5 mercaptoethanol 
(D10FBS)  and overlayed on  a  nylon-wool column  (300  mg);  Fenwal  Laboratories Inc.,  Morton 
Grove,  Ill.)  and  preincubated with  D10FBS  at  37°C  for  1 h  (20).  The  column with  cells  was 
incubated at 37°C for 45 min, and the nonadherent cells eluted with 30 ml of D10FBS. The cells 
were  washed once,  counted,  suspended to  the  desired concentration in  D2FBS,  and plated on 
radioactive Linbro plates containing a freshly plated monolayer of resident macrophages, with or 
without  PPD.  10-25%  of  the  peritoneal  cells  were  recovered  after  passage  over  nylon-wool 
columns, of which fewer than 1% were macrophages. Cell viability, by trypan blue exclusion, was 
greater than 97%. 
Nonadherent Cells.  BCG-primed peritoneal cells were incubated in D10FBS for 1 h at 37°C,  1 
× 10  ~ cells per 100-ram tissue culture dish (Falcon Plastics, Div. of BioQuest, Oxnard, Calif.). The 
nonadherent cells  were  removed and pooled  with cells removed by two  gentle washes  of the 
adherent monolayer. Cells were collected by centrifugation, resuspended in D2FBS, and added to 
monolayers of resident macrophages on ~25I-fibrin plates. 10-20% of peritoneal cells were recovered 
by this procedure with fewer than 5% macrophages. 
Anti-Thy 1.2 Treatment.  AKR anti-ASL1 (anti-thy 1.2) serum was kindly provided by Dr. U. 
Hiimmerling of the Sloan-Kettering Institute, N.  Y. Peritoneal cells were obtained from four to 
six  Balb/cJ  or  C3H/HeJ  mice  21-25  days  after  BCG  infection.  After  washing,  the  cells  were 
resuspended in RPMI-1640  +  1% FBS,  2  x  107/ml, divided into equal groups,  and treated with 
antiserum or normal mouse serum (1/30 vol/vol), with or without selected rabbit serum (1/30 vol/ S.  GORDON  AND  Z.  A.  COHN  1177 
vol) as source of complement, and a  trace amount of deoxyribonuclease. Each group of cells was 
incubated at 37°C for 45 min, washed, and resuspended to the same volume in D2FBS. The treated 
cells were then incubated in  ~25I-fibrin plates for 1-2 days,  with or without PPD,  before assay. 
Treatment  with anti-thy  1.2  serum  and  complement  killed  24-31%  of the  peritoneal  cells,  as 
measured by trypan blue exclusion, and 7-16% of the cells were killed by either reagent alone. 
Fibrinolysis.  Fihrinolytic activity was  measured either by cultivating cells directly on  125I- 
fbrin or by a  two-stage assay in which supernates, prepared by incubating cells with antigen, 
were added to monolayers of resident macrophages on ~2sI-fibrin. 
Direct Assay.  Peritoneal cells were plated on l~I-fihrin as described above and incubated at 
37°C for 1-2 days with the desired concentration of PPD before assay. 
Indirect Assay 
PREPARATION OF SUPEnNATE.  Control  and  BCG-primed  peritoneal  cells  were  incubated  in 
D2FBS with or without 1-50 pg PPD for 1-3 days at 37°C.  Supernates were collected, centrifuged 
at 250 g  for 15 rain, and passed through a 0.45-~m Millex filter (Millipore Corp., Bedford, Mass.). 
Supernates were stable during storage at -70°C. 
INDUCTION OF ~nRINOLYSIS.  Resident peritoneal cells, containing 3-5  ×  105 macrophages per 
well, were cultivated on ~I-fibrin in D2FBS for 2 h  at 37°C.  The macrophage monolayers were 
washed twice with HBSS and incubated for 1-3 days with supernates diluted in D2FBS before 
assay. 
125I-fibrin-coated Linbro plates were  prepared  as  described  (21).  Each  well contained 20  ~g 
fibrinogen  and  1  ×  l0  S cpm  125I releasable  by  trypsin.  Assays  were  run  in  duplicate,  and 
appropriate  controls  were  included  in  all  experiments.  Media  were  monitored  for  release  of 
radioactivity before each change of medium.  The assay of fbrinolysis was started by washing 
cells twice in HBSS followed by incubation in 0.5 ml Dulbecco's medium containing 5% dog serum 
which had been acid-treated to  destroy  inhibitors (pH  2/30 min at room  temperature).  100-pl 
aliquots of medium were withdrawn at intervals (1-6 h) and assayed for release of radioactivity in 
a  Packard  gamma  counter  (Packard  Instrument Co.,  Inc.,  Downers  Grove,  Ill.).  Under these 
conditions, fibrinolysis is strictly dependent on the presence of plasminogen and is therefore due 
to macrophage PA. 
Lysozyme activity was measured as described (22). 
Reagents.  FBS and dog serum  were obtained from Grand Island Biological  Co.  Endotoxin 
(Salmonella abortus equi) was a gift from Professor O. Westphal, Freiburg, Germany. Plasmino- 
gen was purified from dog serum by lysine-sepharose chromatography (23). 
Results 
BCG  Infection  and  Challenge  with  Antigen  in  Vivo.  The  influence  of 
systemic infection and intraperitoneal challenge with various antigenic stimuli 
on  macrophage  fibrinolysis  was  first  examined.  Peritoneal  macrophages  ob- 
tained from animals 3 wk after infection with 2-6 × 10  ~ viable organisms spread 
rapidly in culture, but showed only a  modest, twofold increase in fibrinolytic 
activity (Table I). Higher levels of macrophage fibrinolysis were observed when 
BCG-primed  animals  were  challenged  with  specific  antigen  2  days  before 
harvest.  Two  soluble  antigen  preparations,  PPD  and  M.  tuberculosis  CF, 
further enhanced activity fourfold in infected animals.  A particulate antigen, 
H~TRa, also resulted in a significant increase in uninfected controls, perhaps the 
result of phagocytic stimulation (12). Proteose peptone provided a less effective, 
but definite, nonspecific stimulus in infected animals. Inasmuch as nonspecific 
challenge with these antigens did not enhance macrophage fibrinolysis to the 
same  extent,  it  seemed  likely  that  PA  was  induced  by  an  immunologically 
specific mechanism. 
In Vitro Challenge of BCG-Primed Peritoneal Cells.  We next sought condi- 
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TABLE I 
Effect of Intraperitoneal Challenge on the Fibrinolytic Activity 
of Cultivated Macrophages from Mice Infected with BCG* 
Treatment 
Infection  Challenge 
PA 
Control 
%  radioactivity  re- 
leased~4 h/lO 6 cells 
Nil  2.0 
PP  1.5 
H37Ra  6.1 
CF  1.5 
PPD  2.5 
BCG  Nil  4.5 
PP  7.5 
H3~Ra  13 
CF  15 
PPD  18 
* Mice were infected  intravenously with  2-6 × 107  viable  BCG. After  3 
wk the animals were injected  intraperitoneally  with 1 ml of a 1% 
solution  of  proteose  peptone (PP),  500 ~g H37Ra, 0.1 ~g CF or 50 pg 
PPD. Peritoneal  cells  were harvested after  2  days  and were  cultivated 
in D20STI for  24 h before  assay. 
Peritoneal cells were obtained from mice infected 3 wk earlier with BCG,  and 
the unfractionated  population of macrophages  and  tymphocytes incubated on 
125I-fibrin with different amounts of PPD for 1 or 2 days. The cultures were then 
washed to remove nonadherent  cells and the fibrinolytic activity of the macro- 
phage monolayer determined. As shown in Fig. 1, the addition of PPD to BCG- 
primed cultures resulted in a striking dose-related enhancement of macrophage 
fibrinolytic activity. Stimulation  of fibrinolysis was fully evident within  1 day 
of incubating peritoneal cells with PPD and was maximal,  in this experiment, 
at a  concentration of 2 /~g/ml.  A higher concentration of PPD, up to 50 ~g/ml, 
was required for maximal  fibrinolysis with cells from some groups of infected 
animals,  and the optimal concentration of PPD was determined by titration in 
all subsequent experiments. 
Control experiments showed that two different preparations of antigen, PPD 
and  M.  tuberculosis  CF,  could both be used  for  challenge  in  vitro  and  that 
purified endotoxin, an inducer of macrophage PA in vivo (12), did not stimulate 
fibrinolysis by BCG-primed cells in culture. The fibrinolysis observed after PPD 
stimulation was strictly dependent on plasminogen and the presence of macro- 
phages. 
From these experiments,  we concluded the exposure of BCG-primed perito- 
neal cells to PPD in vitro provided an effective secondary stimulus for induction 
of macrophage PA. 
Time-Course  of Infection.  We next examined the effect of duration of BCG 
infection on the enhancement of macrophage fibrinolysis by in vitro challenge 
with PPD.  As shown in Fig.  2 b, enhancement  of macrophage flbrinolysis by 
PPD  was detectable within  2 wk,  became maximal  after  3 wk,  and  declined S.  GORDON  AND  Z.  A.  COHN  1179 
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F1o.  1.  Enhanced macrophage fibrinolysis after challenge of BCG-primed cells with PPD 
in vitro. Peritoneal cells were harvested 26 days after infection with BCG or from control, 
uninfected animals.  Cells were cultivated for 1 or 2 days on '25I-labeled fibrin plates in 
D2FBS with or without PPD, washed, and the resulting macrophage monolayer assayed for 
fibrinolytic activity. 
subsequently.  Enlargement  of spleen  (Fig.  2  a)  and  liver followed a  roughly 
similar  time-course,  but was noted earlier  and  diminished  more slowly with 
time. Fig. 2 c shows further that the three to fourfold stimulation of fibrinolysis 
by PPD was selective,  whereas  lysozyme secretion by the same  macrophages 
was unaffected. 
Sensitized  Lymphocytes  and PPD Induce Fibrinolysis  in Resident Macro- 
phages.  To  learn  more  about  the  nature  of the  antigen-sensitive  cells,  we 
next  separated  the  lymphoid  and  macrophage  elements  of the  BCG-primed 
peritoneal cavity. Cells were passed over nylon-wool columns to remove macro- 
phages,  and  nonadherent  lymphocytes were  then  co-cultivated  with  control 
resident  macrophages with or without PPD.  After incubation for 1 or 2 days, 
the  lymphocytes  were  removed  by  washing,  and  macrophage  fibrinolysis 
assayed.  Figs.  3  and  4  illustrate  experiments  in  which  nylon  wool purified 
sensitized  lymphocytes  and  PPD  stimulated  fibrinolysis  by  resident  macro- 
phages approximately fourfold, whereas lymphocytes from uninfected animals 
had no such activity. In control experiments,  not shown, BCG-primed lympho- 
cytes displayed no fibrinolytic activity in the absence of macrophages and died 
within  1-2 days in culture. 
Induction of fibrinolysis in resident macrophages was proportional to the dose 
of PPD  (Fig.  3)  and  to  the  number  of sensitized  lymphocytes  (Fig.  4).  The 
optimal  concentration  of  PPD  varied  from  5  to  50  ~g/mt,  and  enhanced 
fibrinolysis  could  be  detected  at  a  lymphocyte:  macrophage  ratio  of  1:40, 
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FIG.  2.  Effect of duration of BCG infection on enhancement of macrophage fibrinolysis by 
PPD.  Groups  of mice  were  infected  at  weekly  intervals  with  BCG,  2-6  ×  107  viable 
organisms,  intravenously.  Peritoneal cells were  cultivated on  ~25I-fibrin  plates,  i  ×  106 
cells/well,  in  the presence or  absence of 10  /~g/ml  PPD,  for  1 day.  Cultures  were  then 
washed, and macrophage fibrinolysis and lysozyme secretion determined. (a) Spleen index; 
(b) fibrinolysis; (c) ratio of fibrinolysis and lysozyme secretion with and without PPD. 15- 
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FIG. 3.  Stimulation of fibrinolysis  in resident macrophages  by BCG-primed  lymphocytes 
and PPD. Nylon-wool-separated  lymphocytes  were prepared 26 days after infection  or from 
control, uninfected  animals.  4  x  10  ~ lymphocytes  were added to 125I-fibrin-coated plates 
containing 4  x  105 resident macrophages/well and incubated in D2FBS with different 
concentrations of PPD, for 2 days, before assay. 
sensitized lymphocytes and resident macrophages with PPD for i or 2 days gave 
similar results. 
The enrichment of antigen-sensitive lymphocytes in BCG-primed cell popu- 
lations  is  shown  in  Table  II  and  compares  the  induction  of  macrophage 
fibrinolysis by unfractionated peritoneal cells,  nylon-wool separated lympho- 
cytes, and lymphocytes separated by nonadherence to a tissue culture dish. Cell 
recovery for nylon-wool separated and nonadherent lymphocytes was  11  and 
6%, but recovery of PPD-dependent induction of fibrinolysis was 33 and 27% for 
each fraction, indicating a  possible enrichment of three- to fourfold in specific 
activity.  This  estimate  is  approximate  because  of the  intrinsic  activity of 
macrophages in the various fractions. 
Role of Thymus-Derived  (T) Lymphocytes.  Induction of macrophage fibri- 
nolysis by infection with T.  cruzi  (17) requires  T  lymphocytes. To establish 
whether T cells also play a part in BCG infection, peritoneal cells obtained 3 wk 
after infection were exposed to anti-thy 1.2 antiserum with or without comple- 
ment and then incubated in the presence or absence of PPD  for 1 day before 
assay. As shown in Table III, pretreatment with anti-thy 1.2  antiserum with 
complement prevented the  PPD-dependent  stimulation of macrophage  fibri- 
nolysis, whereas treatment with either reagent alone resulted in three- to five- 
fold enhancement of activity. The low levels of PPD-independent activity were 1182  BACILLE  CALMETTE-GU~.RIN  INFECTION  IN  THE  MOUSE 
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FIG.  4.  Dose response of stimulation of macrephage fibrinolysis by BCG-primed ]ympho- 
cytes with PPD. Nylon-wool-separated lymphocytes were obtained from control, uninfected 
animals  or  24  days  after  BCG  infection.  Suspensions  of  lymphocytes  were  added  to 
monolayers containing 3  ×  l0  s resident macrophages/well and cultivated in D2FBS, with 
or  without 20  pg  PPD,  for 2  days,  before  assay.  (O--(I)  BCG  lymphocytes with PPD: 
(©--©)  BCG lymphocytes without PPD;  (B---.) control lymphocytes with PPD;  (D--D) 
control lymphocytes without PPD. 
not influenced.  Induction of macrophage fibrinolysis by PPD in BCG infection 
therefore depends on sensitized T lymphocytes. 
Supernatant Inducer of Macrophage PA.  Lymphoid cultures release soluble 
mediators which enhance macrophage fibrinolysis after sensitization  and spe- 
cific challenge  (17)  or  after  lectin  stimulation  (24,  25).  Peritoneal  cells  from 
BCG-infected and control animals were therefore incubated with PPD, and the 
supernate added to resident macrophages.  Fig. 5 a illustrates an experiment in 
which supernate from BeG-primed cells challenged with PPD enhanced  mac- 
rophage fibrinolysis more than fourfold, whereas control supernate or medium 
showed  no  such  effect.  A  dose-response  experiment  (Fig.  5  b)  showed  that 
stimulation of fibrinolysis was maximal at a  supernatant  concentration  of 25- 
50%, but was detectable at 2.5% vol/vol. 
Because the  fibrinolysis was dependent on plasminogen,  we postulate that 
the active supernate contained an inducer of PA (IPA). Production of IPA was 
detectable within  1 day of antigen challenge, but increased with time and was 
maximal after 2-3 days. Optimal levels of IPA were produced at low concentra- 
tions of serum,  1-5% FBS or 1-10% horse serum.  Higher concentrations of FBS 
were strongly inhibitory. Heat inactivation of serum (56°C/30 rain) had no effect 
nor did the addition of mercaptoethanol.  Although sensitized cells yielded the 
highest  levels  of IPA  activity  after  challenge  with  PPD,  some  preparations 
contained low but significant  levels of activity without PPD.  Spleen cultures 
from BCG-infected animals also generated IPA after stimulation with PPD. 
The effects of supernate  containing  IPA on resident macrophages were also S.  GORDON  AND  Z.  A.  COHN  1183 
TABLE II 
Stimulation  of Fibrinolysis of Resident Macrophages  by BCG-Primed Peritoneal 





-PPD  +PPD 
sp act  yield  sp act  yield 
U/10  :~ cells  U/mouse  U/IO:'  cells  U/mouse 
Peritoneal cells  61  0  0  1.95  12 
Nonadherent  3.6  0.60  0.22  9.0  3.2 
Nylon wool  6.6  0.50  0.33  6.0  4.0 
* Peritoneal cells  were harvested from mice 22 days after  infection  with BCG.  Serial 
dilutions  of  total  peritoneal  cells,  nonadherent and nylon-wool-separated lymphocytes 
were added to monolayers of  resident  macrophages with or  without PPD (10 ~g/ml) and 
cultivated  for  2 days  before  assay. 
5 Fibrinolytic  activity  ofperitoneal  cells  without  resident  macrophages subtracted (1.7 U/ 
1 x 105 cells). 
TABLE III 
Effect of Anti-Thy 1.2 Antiserum and Complement on 




-PPD  +PPD 
Anti-thy 1.2 
Normal  mouse  serum 
+ rabbit complement 
Anti-thy  1.2  +  rabbit 
complement 
% radioactivity released~4 h 
3.4  19 
4.9  15 
4.5  5.7 
* Peritoneal cells were obtained from six male Balb/c mice 21 days after 
infection with BCG. After treatment with antiserum and complement 
(see Materials and  Methods), 4  ×  105  cells were incubated on  125I- 
fibrin with or without 50/~g PPD for 1 day before assay. 
studied.  Enhanced  fibrinolysis  was  noted  after  1  day,  but  increased  with 
duration of exposure and was maximal  at 3 days. Macrophages that had been 
exposed to  active  supernates  spread  more  extensively than  controls,  showed 
active membrane ruffling, and accumulated numerous phase-dense granules in 
the perinuclear region.  Such activated resident macrophages did not show the 
toxicity sometimes  seen  with  macrophages  from  BCG-infected  animals  after 
PPD challenge  in the presence of sensitized lymphocytes. Lysozyme secretion 
by macrophages was not enhanced by exposure to supernates rich in IPA (not 
shown). 
Discussion 
BCG  infection  in  the  mouse  elicits  a  variety  of  humoral  and  cellular 
responses, among which effects on lymphocyte and macrophage function feature 
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FIG.  5.  Induction  of macrophage  fibrinolysis  by peritoneal  cell supernates aftar BCG 
infection and PPD. Cells obtained from control animals or 30 days after infection with BCG 
were cultivated for 2 days on nonradioactive Linbro plates 1 x  10  ~ cells/well, in D2FBS, 
with or without PPD. Supernates were then added at different concentrations to resident 
macrophages on ~2~I-fibrin plates, 4 x  105/well, for 3 days before assay.  (a) Macrophage 
fibrinolysis,  concentration  of supernates  25%  vol/vol; (b)  dose response  of supernate 
prepared from BCG-primed cells after challenge with 25 ~g/ml PPD. 
fibrinolysis are  induced under conditions that parallel  the expression of cell- 
mediated  immunity  and  DTH  (26).  Enhanced fibrinolysis  can  be  elicited by 
specific challenge  of BCG-primed  animals  in  vivo or  of sensitized  peritoneal 
cells directly in culture. The antigen-sensitive response depends on T-lympho- 
cytes  that  may  stimulate  fibrinolysis  by  macrophages  from  uninfected  and 
infected animals either after co-cultivation or by the release of soluble media- 
tors.  Enhanced fibrinolysis is  due  to  macrophage  PA  and  is regulated  by an 
immunologically  specific mechanism,  as  shown  by these  and  related  studies 
with T. cruzi. Although highest levels of macrophage fibrinolysis were observed 
when  BCG-  and  T.  cruzi-immune  animals  were  challenged  with  specific 
antigen,  nonspecific stimulation  of PA  may follow direct challenge of primed 
macrophages  with  a  particulate  stimulus.  The  present  system  offers  the 
advantage of a  soluble antigen.  Further evidence for immunologically specific 
regulation of macrophage PA has been provided by studies of mixed leukocyte 
culture reactions in the mouse  ~ and of hypersensitivity to PPD in guinea pigs 
immunized with Freund's adjuvant  (25). 
Our results draw attention to the role of antigen restimulation and of T cells 
in  control  of  macrophage  activation.  No  significant  fibrinolysis  was  found 
without  secondary challenge,  although  the peritoneal cavity of BCG-infected 
mice contained substantial numbers of sensitized T cells, as noted previously by 
others  (27).  These  sensitized  lymphocytes  responded  rapidly  to  PPD,  and 
measurement of macrophage fibrinolysis provided a  sensitive and quantitative 
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measure of their generation in the peritoneal cavity during infection. In the 
course of infection, the sensitization of peritoneal lymphocytes becomes appar- 
ent somewhat later and declines more rapidly than enlargement of the spleen 
and liver. It is possible that sensitized cells persist longer in the spleens of BCG- 
infected animals than after infection with T.  cruzi  (17). The decline of PPD- 
stimulated fibrinolysis by peritoneal cells at later stages of infection could be 
due to either loss or inhibition of sensitized T cells. 
Induction of macrophage PA by specific antigen depends on T lymphocytes in 
BCG infection, as with T. cruzi  (17) and the mixed leukocyte culture reaction 
(see fn. 2). T cells are known to play a role in antimicrobial protection in BCG- 
infected mice (3, 27) and rats (28) and in development of DTH to tuberculin (29, 
30). Nothing is known, however, about the frequency, heterogeneity, or prolif- 
erative characteristives of T cells that regulate macrophage fibrinolysis or their 
relation to protective and memory cells generated by BCG. 
Stimulation of fibrinolysis by BCG infection provides a  particularly useful 
model system to study interactions between sensitized lymphocytes, antigen, 
and macrophages under defined conditions in  culture.  Titration  experiments 
with  nylon-wool-separated  lymphocytes and  active  supernates  showed  that 
direct contact and soluble  mediators stimulated macrophage fibrinolysis to a 
similar extent.  The 2-stage assay offers the possible advantage of separating 
production of a PA inducer from its action on macrophages, although it is likely 
that macrophages also play a role in secondary stimulation of sensitized T cells 
by antigen (31, 32). A particular advantage of the BCG model, however, is that 
sensitized lymphocytes and PPD can be titrated directly on macrophages from 
uninfected animals. The sensitivity of the fibrinolytic assay is greatly enhanced 
by serum-free conditions, and it may be possible to determine the activity and 
number of sensitized peritoneal lymphocytes by limiting dilution analysis. 
The nature of the inducers of macrophage PA remains obscure, although it is 
known that lymphocytes release similar products after stimulation with lectins 
(24,  25).  The  IPA generated by  MLC  reactions closely resembles migration 
inhibition factor in activity, size,  and in production by both Ly-1 and Ly-2,3 
subsets  of T  lymphocytes (see fn.  2).  Other  workers have reported that  PA 
produced by transformed fibroblasts is itself able to generate MIF-like activity 
from undefined serum components (33). The supernatant inducer of macrophage 
PA studied in the present report cannot be  PA itself because no fibrinolytic 
activity could be  detected before incubation  with  macrophages  and  because 
medium  conditioned  by  thioglycolate broth-stimulated  macrophages,  a  rich 
source of PA, did not enhance fibrinolysis by unstimulated macrophages. The 
relationship  between IPA,  MIF,  PA,  and  serum zymogens clearly deserves 
further study. 
Products  of stimulated  lymphocytes have  several  effects on  macrophages 
other than stimulating PA and inhibiting migration (34). Responses of macro- 
phages  reported include enhanced secretion of collagenase  (35),  C2  (36), and 
pyrogens (37), increased plasma membrane spreading, ingestion of EIgMC via 
receptors for C3b,  3 and formation of giant cells (38). The present studies show 
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that  lysozyme production  is,  however,  not  influenced.  Purification  of IPA is 
necessary  to  determine  whether  the  multiple  macrophage  responses  are  me- 
diated by a common molecular mediator. 
Induction of macrophage PA by T cells provides an important  mechanism to 
amplify lymphocyte function,  to generate various mediators of inflammation, 
and  may  also  contribute  to  connective  tissue  catabolism  and  tissue  injury 
associated with DTH in tuberculosis.  Activation of macrophages by this path- 
way can be augmented by endocytic stimuli and by humoral mediators gener- 
ated by activation of complement and coagulation cascades (39). The mechanism 
by which BCG-activated macrophages could acquire antimicrobial  and antitu- 
mor cell activity, however, remains unknown. 
Summary 
High levels of plasminogen activator (PA) were induced in mouse peritoneal 
macrophages by infection with BCG, 2-6 ×  107 viable organisms intravenously, 
followed 3-4 wk later by intraperitoneal challenge with purified protein deriva- 
tive (PPD) 2 days before harvest.  Macrophages obtained from infected animals 
without  boosting showed little  fibrinolytic  activity,  but challenge  of Bacille- 
Calmette-Gu~rin  (BCG)-primed  peritoneal  cells  with  PPD  in  culture  also 
enhanced macrophage PA 4- to 10-fold.  Stimulation of macrophage PA by PPD 
depended on specifically sensitized thymus-derived (T) lymphocytes because it 
was abolished by pretreatment of BCG-primed peritoneal cells with anti-thy 1.2 
antiserum and complement. A direct assay was developed in which nylon wool 
separated  sensitized  lymphocytes and  PPD  induced PA in  macrophages  from 
uninfected  animals  under  defined conditions  on  125I-fibrin.  Enhanced  macro- 
phage fibrinolysis was proportional to concentration of PPD and the number of 
sensitized lymphocytes transferred.  An indirect two-stage assay was also used 
to  show  that  BCG-sensitized  peritoneal  cells  released  a  soluble  inducer  of 
macrophage PA into the culture medium, after challenge with PPD. 
Induction  of macrophage  PA by PPD challenge  in vitro made it possible to 
study  the  generation  and  activity  of  sensitized  peritoneal  lymphocytes  at 
different stages of infection. Our results show that nonadherent peritoneal cells 
of BCG-infected mice provide a rich source of specifically sensitized lymphocytes 
and that macrophage activation is limited by continued availability of antigen, 
as  well  as  sensitized  lymphocytes.  Induction  of macrophage  PA  provides  a 
sensitive,  versatile,  and rapid in vitro assay to study the role of lymphocytes 
and specific antigen in macrophage activation by BCG. 
We thank Eileen Fontanetta, Renee Zweibel, and Ann Chin for their assistance. 
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